Drenagem linfática manual no controle glicêmico em mulheres diabéticas na pré-menopausa e menopausa

Abstract

The hormones estrogen and progesterone regulate glucose absorption and affect insulin resistance. During menopause, there is a decline in these hormones, which leads to a reduction in insulin secretion by the pancreas and predisposes the development of diabetes mellitus (DM). Type 1 and Type 2 DM affect a total of 537 million adults worldwide, and in Brazil, 16.8 million people have this disease, with women experiencing a 9% increase in 2020. This justifies the importance of this research in analyzing the effectiveness of DLM, dietary consumption, bioimpedance, and glucose levels in diabetic women, whether or not they are menopausal. Nine adult women (aged 25-75) with Type 1 or Type 2 DM and fasting blood glucose levels above 126 mg/dL participated, divided into 5 menopausal diabetic women (DM/M) and 4 pre menopausal diabetic women (DM/pM). Both groups completed questionnaires regarding sociodemographic data (before DLM), dietary consumption, quality of life, bioimpedance testing, and glucose and glycated hemoglobin exams (before and after DLM). Both groups received ten sessions of DLM, once a week. It was possible to observe a reduction in glucose and glycated hemoglobin in the DM/M group, but this was not statistically significant. The pre-menopausal participants showed concerning data regarding glucose levels, glycated hemoglobin, and body mass index (BMI), indicating obesity. Given that these levels tend to increase when they enter menopause, this raises concerns about the development of new diseases. There were no changes in bioimpedance data or quality of life scores related to DLM in either group.